"The cost of inaction to tackle AMR is high," the report states. "Results from the OECD analysis demonstrate that policy action that is grounded in a One Health approach is urgently needed to tackle AMR."

"Scaling up investments in One Health packages of actions against AMR is affordable, with a return on investment significantly greater than implementation costs," the report concludes. "The health and economic benefits of implementing One Health policies as policy packages far exceed the benefits accrued by implementing these policies in isolation."

SEE: (OECD) calls for package of One Health policies to limit impact of antibiotic resistance | CIDRAP (